×
欢迎光临本店! 登录 注册
服务热线:

400-000-7085

购物车暂无商品,赶紧选购吧!
SK-MEL-28细胞(人皮肤恶性黑色素瘤细胞)
SK-MEL-28细胞(人皮肤恶性黑色素瘤细胞)
  • 商品货号:CL0284
  • ¥1500元
    已售 9 件 | 评价 0 人次 | 关注度 2831
    浏览历史清除
    • 细胞信息
     
    发货规格 1×10⁶
    别名 SK-Mel-28; SK.MEL.28; SK-MEL 28; SK MEL-28; SK MEL 28; SK Mel 28; SKMel-28; SKMEL-28; SK-MEL28; SK-Mel28; SK Mel28; SKMEL28; SKMel28; SKmel28; SKML-28; SK28; AU-Mel; P-36; P36
    形态 多角形
    生长特性 贴壁
    培养条件 RPMI-1640+10%FBS+1%P/S
    冻存条件 90%FBS+10%DMSO
    传代方式 胰酶消化
    倍增时间 27h
    传代比例 1:2~1:4
    换液频率 每周2~3次
    生物安全等级 1
    • 细胞背景
     
    种属 人源
    组织来源 皮肤
    肿瘤类型 皮肤黑色素瘤
    供体信息 51岁男性
    背景描述 该细胞系是由 T.Takahashi 及其同事从一名种族不明的 51 岁男性的腋窝淋巴结中建立的,他们在一系列黑色素瘤系中分离出该细胞系。
    • 遗传背景
     
    蛋白表达 p53 positive
    同工酶 PGM3, 1, PGM1, 1, ES-D, 1, AK-1, 1-2, GLO-1, 2, G6PD, B
    致瘤性 Yes, in nude mice. Forms malignant melanoma (large round cell type)
    抗原表达 Blood Type A; Rh+; HLA A11, A26, B40, DRw4
    突变信息 BRAF V600E mut: V600E type BRAF Mutation was determined by DNA based methods (sequencing, RT-PCR) and protein based methods (Western Blot), N-Ras wt
    核型 modal number = 90; range = 81 to 96. This is a hypotetraploid human cell line with the modal chromosome number of 90, occurring in 50% of cells. The rate of cells with a higher ploidy was 3.6%. This cell line has a very complex karyotype. There were 18 or more marker chromosomes that were common to most cells. Markers der(1)t(1;2) (p36.1;q21), del(1) (q2101) and several others had two copies per cell and t(2p14q), t(3q7p) and others had a single copy per cell. The Y/autosome translocation marker was identified as der(20)t(Y;20) (q11.23;q13.3) and had two copies per cell. The inclusion of a short segment of the euchromatic Yq11.23 was confirmed by the Southern blot DNA analysis. There were two normal X chromosomes per cell; Normal Y, N1 and N11 were absent; N19 had five or more copies per cell.
    STR鉴定
    STR位点信息
    STR鉴定图
    Amelogenin X,Y
    CSF1PO 10 (PubMed=19372543; PubMed=25877200) 10,12 (AddexBio=C0020001/66; ATCC=HTB-72; CLS=300337; Cosmic-CLP=905954; PubMed=27087056; RCB=RCB1930)
    D2S1338 18
    D3S1358 16,18
    D5S818 11,13 (AddexBio=C0020001/66; ATCC=HTB-72; Cosmic-CLP=905954; PubMed=27087056; RCB=RCB1930) 13 (CLS=300337; PubMed=19372543; PubMed=25877200)
    D7S820 9.3,10 (AddexBio=C0020001/66; ATCC=HTB-72) 10 (CLS=300337; Cosmic-CLP=905954; PubMed=19372543; PubMed=25877200; PubMed=27087056; RCB=RCB1930)
    D8S1179 13
    D13S317 11,12
    D16S539 9,12
    D18S51 12,16
    D19S433 14
    D21S11 28,29
    FGA 19
    Penta D 9,10
    Penta E 8,12
    TH01 7
    TPOX 8,12 (AddexBio=C0020001/66; ATCC=HTB-72; CLS=300337; Cosmic-CLP=905954; PubMed=27087056; RCB=RCB1930) 12 (PubMed=19372543; PubMed=25877200)
    vWA 16,19 (AddexBio=C0020001/66; ATCC=HTB-72; CLS=300337; Cosmic-CLP=905954; PubMed=25877200; PubMed=27087056; RCB=RCB1930) 19 (PubMed=19372543)